Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 2/20 | 0.38 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.38 |
| ▸ | P2RX4 | Q99571 | 2/20 | 0.38 |
| ▸ | P2RX2 | Q9UBL9 | 2/20 | 0.38 |
| ▸ | TYMS | P04818 | 3/20 | 0.37 |
| ▸ | P2RX6 | O15547 | 1/20 | 0.35 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.35 |
| ▸ | P2RX5 | Q93086 | 1/20 | 0.35 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.35 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.34 |
| ▸ | P2RY12 | Q9H244 | 3/20 | 0.34 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.34 |
| ▸ | GAPDH | P04406 | 1/20 | 0.33 |
| ▸ | RNASE1 | P07998 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.33 |
| ▸ | DTYMK | P23919 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19777696 | 1.00 | TYMP (0.38) | TYMPP2RX3P2RX4P2RX2TYMS | |
| SCHEMBL21389678 | 0.96 | TYMP (0.38) | TYMPP2RX3P2RX4P2RX2TYMS | |
| SCHEMBL19777694 | 0.96 | TYMP (0.38) | TYMPP2RX3P2RX4P2RX2TYMS | |
| SCHEMBL19780271 | 0.92 | P2RX3 (0.41) | P2RX3P2RX4P2RX2TYMSP2RX6 | |
| SCHEMBL19777697 | 0.92 | P2RX3 (0.41) | P2RX3P2RX4P2RX2TYMSP2RX6 | |
| SCHEMBL19780111 | 0.92 | P2RX3 (0.41) | P2RX3P2RX4P2RX2TYMSP2RX6 | |
| SCHEMBL21389679 | 0.92 | P2RX3 (0.41) | P2RX3P2RX4P2RX2TYMSP2RX6 | |
| SCHEMBL21389685 | 0.88 | P2RX3 (0.34) | TYMPP2RX3P2RX4P2RX2TYMS | |
| SCHEMBL21389676 | 0.88 | P2RX3 (0.41) | P2RX3P2RX4P2RX2TYMSP2RX6 | |
| SCHEMBL27216216 | 0.80 | KDM4E (0.39) | TYMPP2RY12GAPDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190292215-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE | SPEROVIE BIOSCIENCES, INC. | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190292215-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE | STING1, CGAS, MYD88 | TYMP 1870/4885P2RX3 222/4885P2RX4 612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.